ARID1A orchestrates SWI/SNF-mediated sequential binding of transcription factors with ARID1A loss driving pre-memory B cell fate and lymphomagenesis-Reference-Cited by-同舟云学术

ARID1A orchestrates SWI/SNF-mediated sequential binding of transcription factors with ARID1A loss driving pre-memory B cell fate and lymphomagenesis

Published:2024-04 Issue:4 Volume:42 Page:583-604.e11
ISSN:1535-6108
Container-title:Cancer Cell
language:en
Short-container-title:Cancer Cell

Author:

Barisic Darko,Chin Christopher R.,Meydan Cem,Teater Matt,Tsialta Ioanna,Mlynarczyk Coraline,Chadburn Amy,Wang Xuehai,Sarkozy Margot,Xia Min,Carson Sandra E.,Raggiri Santo,Debek Sonia,Pelzer Benedikt,Durmaz Ceyda,Deng Qing,Lakra Priya,Rivas Martin,Steidl Christian,Scott David W.,Weng Andrew P.,Mason Christopher E.,Green Michael R.,Melnick Ari^ORCID

Funder

National Cancer Institute

Leukemia & Lymphoma Society

Publisher

Elsevier BV

Reference111 articles.

1. A mammalian DNA-binding protein that contains a chromodomain and an SNF2/SWI2-like helicase domain;Delmas;Proc. Natl. Acad. Sci. USA,1993

2. A chromatin remodelling complex involved in transcription and DNA processing;Shen;Nature,2000

3. ISWI, a member of the SWl2/SNF2 ATPase family, encodes the 140 kDa subunit of the nucleosome remodeling factor;Tsukiyama;Cell,1995

4. brahma: A regulator of Drosophila homeotic genes structurally related to the yeast transcriptional activator SNF2SWI2;Tamkun;Cell,1992

5. Nucleosome mobilization catalysed by the yeast SWI/SNF complex;Whitehouse;Nature,1999

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Arid1a-dependent canonical BAF complex suppresses inflammatory programs to drive efficient germinal center B cell responses;Nature Immunology;2024-08-14

2. Transcription factor dependencies identify BAF-dependent cancers;Cancer Cell;2024-08

3. Targeting the mSWI/SNF complex in POU2F-POU2AF transcription factor-driven malignancies;Cancer Cell;2024-08

4. IRF4 requires ARID1A to establish plasma cell identity in multiple myeloma;Cancer Cell;2024-07

5. Multiomic analysis identifies a high-risk signature that predicts early clinical failure in DLBCL;Blood Cancer Journal;2024-06-20